287 related articles for article (PubMed ID: 27483358)
1. Comparison of the long-term effects of single-dose methotrexate and salpingectomy on ovarian reserve in terms of anti-müllerian hormone levels.
Sahin Ersoy G; Turhan OT; Sakin O; Bulut S
Hum Fertil (Camb); 2016 Dec; 19(4):262-267. PubMed ID: 27483358
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of single or multiple dose methotrexate administration, salpingectomy on ovarian reserve of rat with the measurement of anti-Müllerian hormone (AMH) levels and histological analysis.
Ulug P; Oner G
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():205-9. PubMed ID: 25171264
[TBL] [Abstract][Full Text] [Related]
3. The impact of salpingectomy and single-dose systemic methotrexate treatments on ovarian reserve in ectopic pregnancy.
Sahin C; Taylan E; Akdemir A; Ozgurel B; Taskıran D; Ergenoglu AM
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():150-2. PubMed ID: 27592417
[TBL] [Abstract][Full Text] [Related]
4. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
5. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA
Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.
Boots CE; Hill MJ; Feinberg EC; Lathi RB; Fowler SA; Jungheim ES
J Assist Reprod Genet; 2016 May; 33(5):647-656. PubMed ID: 26943917
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of multi-dose methotrexate therapy on ovarian reserve in ectopic pregnancies: is polycystic ovarian morphology a protective condition for ovarian reserve?
Çetin F; Bayramoglu Tepe N; Kutlar AI
Ginekol Pol; 2023; 94(5):407-414. PubMed ID: 36106469
[TBL] [Abstract][Full Text] [Related]
8. Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization-Embryo Transfer Outcomes.
Pereira N; Gerber D; Gerber RS; Lekovich JP; Elias RT; Spandorfer SD; Rosenwaks Z
J Minim Invasive Gynecol; 2015; 22(5):870-6. PubMed ID: 25917279
[TBL] [Abstract][Full Text] [Related]
9. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
10. Effects of treatment of ectopic pregnancy with methotrexate or salpingectomy in the subsequent IVF cycle.
Wiser A; Gilbert A; Nahum R; Orvieto R; Haas J; Hourvitz A; Weissman A; Younes G; Dirnfeld M; Hershko A; Shulman A; Tsafrir A; Holzer H; Shalom-Paz E; Tulandi T
Reprod Biomed Online; 2013 May; 26(5):449-53. PubMed ID: 23518030
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-Müllerian hormone concentration before and after salpingectomy for ectopic pregnancy.
Grynnerup AG; Lindhard A; Sørensen S; Ørskov M; Petersen KR; Madsen LB; Pilsgaard F; Løssl K; Pinborg A
Reprod Biomed Online; 2018 Nov; 37(5):624-630. PubMed ID: 30287173
[TBL] [Abstract][Full Text] [Related]
12. Effect of single-dose methotrexate on ovarian reserve in women with ectopic pregnancy.
Uyar I; Yucel OU; Gezer C; Gulhan I; Karis B; Hanhan HM; Ozeren M
Fertil Steril; 2013 Nov; 100(5):1310-3. PubMed ID: 23891021
[TBL] [Abstract][Full Text] [Related]
13. Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population.
Bozkurt B; Erdem M; Mutlu MF; Erdem A; Guler I; Mutlu I; Oktem M
Hum Fertil (Camb); 2016 Sep; 19(3):192-8. PubMed ID: 27499425
[TBL] [Abstract][Full Text] [Related]
14. The effect of laparoscopic salpingectomy for ectopic pregnancy on ovarian reserve.
Rodgers R; Carter J; Reid G; Krishnan S; Ludlow J; Cooper M; Abbott J
Aust N Z J Obstet Gynaecol; 2020 Apr; 60(2):278-283. PubMed ID: 32065384
[TBL] [Abstract][Full Text] [Related]
15. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
[TBL] [Abstract][Full Text] [Related]
17. The effects of uterine artery embolization on ovarian reserve.
Kim CW; Shim HS; Jang H; Song YG
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():172-176. PubMed ID: 27697621
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ovarian reserve using anti-müllerian hormone and antral follicle count in Sjögren's syndrome: Preliminary study.
Karakus S; Sahin A; Durmaz Y; Aydin H; Yildiz C; Akkar O; Dogan M; Cengiz A; Cetin M; Cetin A
J Obstet Gynaecol Res; 2017 Feb; 43(2):303-307. PubMed ID: 27987339
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Salpingectomy on Ovarian Reserve and Ovarian Function.
Qin F; Du DF; Li XL
Obstet Gynecol Surv; 2016 Jun; 71(6):369-76. PubMed ID: 27302188
[TBL] [Abstract][Full Text] [Related]
20. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
